(Q83845401)
Statements
NICE guidance on cetuximab, bevacizumab, and panitumumab for treatment of metastatic colorectal cancer after first-line chemotherapy (English)
Fiona Rinaldi
Elisabeth George
scientific article published on 01 March 2012
No description defined